Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

1.

Resistance patterns among multidrug-resistant tuberculosis patients in greater metropolitan Mumbai: trends over time.

Dalal A, Pawaskar A, Das M, Desai R, Prabhudesai P, Chhajed P, Rajan S, Reddy D, Babu S, Jayalakshmi TK, Saranchuk P, Rodrigues C, Isaakidis P.

PLoS One. 2015 Jan 21;10(1):e0116798. doi: 10.1371/journal.pone.0116798. eCollection 2015.

2.

Training clinicians treating HIV to diagnose cytomegalovirus retinitis.

Heiden D, Tun N, Maningding E, Heiden M, Rose-Nussbaumer J, Chan KN, Khizniak T, Yakubenko A, Lewallen S, Keenan JD, Saranchuk P.

Bull World Health Organ. 2014 Dec 1;92(12):903-8. doi: 10.2471/BLT.14.142372. Epub 2014 Sep 22.

3.

Alarming levels of drug-resistant tuberculosis in HIV-infected patients in metropolitan Mumbai, India.

Isaakidis P, Das M, Kumar AM, Peskett C, Khetarpal M, Bamne A, Adsul B, Manglani M, Sachdeva KS, Parmar M, Kanchar A, Rewari BB, Deshpande A, Rodrigues C, Shetty A, Rebello L, Saranchuk P.

PLoS One. 2014 Oct 21;9(10):e110461. doi: 10.1371/journal.pone.0110461. eCollection 2014.

4.

Self-administered tuberculosis treatment outcomes in a tribal population on the indo-myanmar border, Nagaland, India.

Das M, Isaakidis P, Shenoy R, Anicete R, Sharma HK, Ao I, Osah K, Mansoor H, Saranchuk P, Abraham S.

PLoS One. 2014 Sep 26;9(9):e108186. doi: 10.1371/journal.pone.0108186. eCollection 2014.

5.

Patch-testing for the management of hypersensitivity reactions to second-line anti-tuberculosis drugs: a case report.

Khan S, Andries A, Pherwani A, Saranchuk P, Isaakidis P.

BMC Res Notes. 2014 Aug 15;7:537. doi: 10.1186/1756-0500-7-537.

6.

We urge WHO to act on cytomegalovirus retinitis.

Heiden D, Saranchuk P, Tun N, Audoin B, Cohn J, Durier N, Holland G, Drew WL, 't Hoen E.

Lancet Glob Health. 2014 Feb;2(2):e76-7. doi: 10.1016/S2214-109X(13)70174-8. Epub 2014 Jan 23. No abstract available.

7.

Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India.

Khan S, Das M, Andries A, Deshpande A, Mansoor H, Saranchuk P, Isaakidis P.

Glob Health Action. 2014 Jul 30;7:24861. doi: 10.3402/gha.v7.24861. eCollection 2014.

8.

Barriers to pilot mobile teleophthalmology in a rural hospital in Southern Malawi.

PĂ©rez GM, Swart W, Munyenyembe JK, Saranchuk P.

Pan Afr Med J. 2014 Oct 9;19:136. doi: 10.11604/pamj.2014.19.136.5196. eCollection 2014.

9.

Viral load for HIV treatment failure management: a report of eight drug-resistant tuberculosis cases co-infected with HIV requiring second-line antiretroviral treatment in Mumbai, India.

Andries A, Das M, Isaakidis P, Saranchuk P.

Am J Trop Med Hyg. 2013 Dec;89(6):1233-4. doi: 10.4269/ajtmh.13-0526. No abstract available.

10.

High rate of hypothyroidism in multidrug-resistant tuberculosis patients co-infected with HIV in Mumbai, India.

Andries A, Isaakidis P, Das M, Khan S, Paryani R, Desai C, Dalal A, Mansoor H, Verma R, Fernandes D, Sotgiu G, Migliori GB, Saranchuk P.

PLoS One. 2013 Oct 23;8(10):e78313. doi: 10.1371/journal.pone.0078313. eCollection 2013.

11.

Feasibility and benefits of scaling up antiretroviral treatment provision with the 2010 WHO antiretroviral therapy guidelines in rural Lesotho.

Bygrave H, Saranchuk P, Makakole L, Ford N.

Int Health. 2012 Sep;4(3):170-5. doi: 10.1016/j.inhe.2012.06.002.

PMID:
24029396
12.

Burden of HIV-related cytomegalovirus retinitis in resource-limited settings: a systematic review.

Ford N, Shubber Z, Saranchuk P, Pathai S, Durier N, O'Brien DP, Mills EJ, Pascual F, Hoen E', Holland GN, Heiden D.

Clin Infect Dis. 2013 Nov;57(9):1351-61. doi: 10.1093/cid/cit494. Epub 2013 Jul 29. Review.

13.

Poor outcomes in a cohort of HIV-infected adolescents undergoing treatment for multidrug-resistant tuberculosis in Mumbai, India.

Isaakidis P, Paryani R, Khan S, Mansoor H, Manglani M, Valiyakath A, Saranchuk P, Furin J.

PLoS One. 2013 Jul 19;8(7):e68869. doi: 10.1371/journal.pone.0068869. Print 2013.

14.
15.

Eye exam with indirect ophthalmoscopy for diagnosis of disseminated tuberculosis in patients with HIV/AIDS.

Heiden D, Margolis TP, Lowinger A, Saranchuk P.

Br J Ophthalmol. 2013 May;97(5):668-9. doi: 10.1136/bjophthalmol-2012-302610. Epub 2013 Feb 16. No abstract available.

PMID:
23418196
16.

Change to patient-centred terminology in tuberculosis: an important step, but what about the treatment strategies?

Biot M, Saranchuk P, Ellman T, Bygrave H, Bemelmans M.

Int J Tuberc Lung Dis. 2012 Nov;16(11):1559-60. doi: 10.5588/ijtld.12.0466. No abstract available.

PMID:
23044452
17.

Retinal examination can help identify disseminated tuberculosis in patients with HIV/AIDS.

Saranchuk P, Bedelu M, Heiden D.

Clin Infect Dis. 2013 Jan;56(2):310-2. doi: 10.1093/cid/cis828. Epub 2012 Sep 20. No abstract available.

18.

Adverse events among HIV/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India.

Isaakidis P, Varghese B, Mansoor H, Cox HS, Ladomirska J, Saranchuk P, Da Silva E, Khan S, Paryani R, Udwadia Z, Migliori GB, Sotgiu G, Reid T.

PLoS One. 2012;7(7):e40781. doi: 10.1371/journal.pone.0040781. Epub 2012 Jul 11.

19.

Ambulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, India.

Isaakidis P, Cox HS, Varghese B, Montaldo C, Da Silva E, Mansoor H, Ladomirska J, Sotgiu G, Migliori GB, Pontali E, Saranchuk P, Rodrigues C, Reid T.

PLoS One. 2011;6(12):e28066. doi: 10.1371/journal.pone.0028066. Epub 2011 Dec 1.

20.

CMV retinitis in China and SE Asia: the way forward.

Heiden D, Saranchuk P.

BMC Infect Dis. 2011 Nov 24;11:327. doi: 10.1186/1471-2334-11-327.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk